Holen Sie sich die Stockscreener-App
6.4049
2.29%
-0.1351
Schlusskurs vom Vortag:
$6.54
Offen:
$6.48
24-Stunden-Volumen:
19,316
Relative Volume:
0.13
Marktkapitalisierung:
$162.92M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.38M
KGV:
-4.5425
EPS:
-1.41
Netto-Cashflow:
$-15.54M
1W Leistung:
-0.62%
1M Leistung:
-19.92%
6M Leistung:
-15.81%
1J Leistung:
-10.63%
1-Tages-Spanne:
$6.355
$6.565
1-Wochen-Bereich:
$6.11
$6.59
52-Wochen-Spanne:
$4.44
$11.80
Nuvectis Pharma Inc Stock (NVCT) Company Profile
Firmenname
Nuvectis Pharma Inc
Sektor
Branche
Telefon
360-837-7232
Adresse
1 BRIDGE PLAZA, SUITE 275, FORT LEE
Vergleichen Sie NVCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVCT
Nuvectis Pharma Inc
|
6.40 | 164.20M | 0 | -22.38M | -15.54M | -1.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.85 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
601.19 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
662.78 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
312.01 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-02 | Eingeleitet | Maxim Group | Buy |
| 2025-03-17 | Eingeleitet | Laidlaw | Buy |
| 2022-07-13 | Eingeleitet | Ladenburg Thalmann | Buy |
Nuvectis Pharma Inc Aktie (NVCT) Neueste Nachrichten
Nuvectis Pharma Inc. stock prediction for this weekShort Setup & Fast Gain Stock Trading Tips - Newser
Nuvectis Pharma Inc. stock chart pattern explained2025 Momentum Check & Fast Gain Stock Tips - Newser
Published on: 2025-08-20 18:42:25 - beatles.ru
Applying Elliott Wave Theory to Nuvectis Pharma Inc.July 2025 Sector Moves & Daily Entry Point Trade Alerts - Newser
Real time alert setup for Nuvectis Pharma Inc. performanceJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - Newser
How to monitor Nuvectis Pharma Inc. with trend dashboardsProfit Target & Technical Pattern Based Signals - Newser
Can machine learning forecast Nuvectis Pharma Inc. recoveryTake Profit & Growth Focused Stock Pick Reports - Newser
Detecting price anomalies in Nuvectis Pharma Inc. with AI2025 Institutional Moves & Fast Exit Strategy with Risk Control - Newser
Published on: 2025-08-19 22:05:38 - Newser
Key resistance and support levels for Nuvectis Pharma Inc.July 2025 Update & Accurate Intraday Trading Signals - Newser
Published on: 2025-08-19 15:27:43 - Newser
Will Nuvectis Pharma Inc. stock recover after recent drop2025 Trading Volume Trends & Daily Profit Maximizing Tips - Newser
Evaluating Nuvectis Pharma Inc. with trendline analysisTrade Signal Summary & Risk Adjusted Buy and Sell Alerts - Newser
What indicators show strength in Nuvectis Pharma Inc.Weekly Market Outlook & Entry Point Confirmation Signals - Newser
Is Nuvectis Pharma Inc. stock bottoming outJuly 2025 Rallies & Real-Time Volume Spike Alerts - Newser
Candlestick signals on Nuvectis Pharma Inc. stock todayJuly 2025 Review & AI Enhanced Trade Execution Alerts - Newser
Reversal indicators forming on Nuvectis Pharma Inc. stock2025 Institutional Moves & Weekly Watchlist for Consistent Profits - Newser
Does Nuvectis Pharma Inc. fit your quant trading modelPrice Action & Risk Controlled Daily Trade Plans - Newser
Nuvectis Pharma Inc. Inches Toward Key Resistance — Will It BreakMarket Sentiment Review & AI Powered Buy and Sell Recommendations - 선데이타임즈
Nuvectis Pharma Inc. stock daily chart insightsCPI Data & Community Consensus Stock Picks - Newser
Is Nuvectis Pharma Inc. building a consolidation baseQuarterly Trade Summary & Weekly Consistent Profit Watchlists - Newser
What makes Nuvectis Pharma Inc. stock price move sharplyQuarterly Trade Summary & Accurate Intraday Trading Signals - classian.co.kr
Will Nuvectis Pharma Inc. benefit from seasonality2025 Trading Recap & AI Enhanced Trading Alerts - classian.co.kr
Developing predictive dashboards with Nuvectis Pharma Inc. dataQuarterly Risk Review & Low Drawdown Trading Strategies - Newser
Volume spikes in Nuvectis Pharma Inc. stock – what they meanQuarterly Market Summary & Daily Chart Pattern Signal Reports - Newser
Why Nuvectis Pharma Inc. stock attracts strong analyst attentionWeekly Trend Recap & Capital Efficiency Focused Ideas - Newser
Real time scanner hits for Nuvectis Pharma Inc. explainedWeekly Gains Report & Free Fast Gain Swing Trade Alerts - Newser
How to track smart money flows in Nuvectis Pharma Inc.Bond Market & Short-Term Trading Opportunity Alerts - Newser
Is Nuvectis Pharma Inc. trending in predictive chart modelsJuly 2025 Earnings & Trade Opportunity Analysis - Newser
Using R and stats models for Nuvectis Pharma Inc. forecastingTrade Volume Report & Real-Time Buy Zone Alerts - Newser
Exit strategy if you’re trapped in Nuvectis Pharma Inc.Buy Signal & Consistent Return Investment Signals - Newser
Nuvectis Pharma Inc. stock volume spike explainedJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Nuvectis Pharma Q3 EPS Estimate Boosted by HC Wainwright - Defense World
Q3 EPS Estimates for Nuvectis Pharma Lifted by Roth Capital - Defense World
Finanzdaten der Nuvectis Pharma Inc-Aktie (NVCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nuvectis Pharma Inc-Aktie (NVCT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mosseri Marlio Charles | 10% Owner |
Jun 18 '25 |
Buy |
8.05 |
28,043 |
225,746 |
2,976,203 |
| Mosseri Marlio Charles | 10% Owner |
Jun 17 '25 |
Buy |
8.11 |
5,399 |
43,786 |
2,948,160 |
| Mosseri Marlio Charles | 10% Owner |
May 12 '25 |
Buy |
8.11 |
21,167 |
171,664 |
2,942,761 |
| Mosseri Marlio Charles | 10% Owner |
May 06 '25 |
Buy |
8.59 |
12,444 |
106,955 |
2,896,565 |
| Mosseri Marlio Charles | 10% Owner |
May 07 '25 |
Buy |
8.59 |
12,317 |
105,770 |
2,908,882 |
| Mosseri Marlio Charles | 10% Owner |
May 08 '25 |
Buy |
8.65 |
2,650 |
22,922 |
2,911,532 |
| Mosseri Marlio Charles | 10% Owner |
Feb 07 '25 |
Buy |
5.00 |
240,000 |
1,200,000 |
2,884,121 |
| BENTSUR RON | Chairman & CEO |
Dec 24 '24 |
Buy |
4.65 |
4,500 |
20,925 |
3,270,924 |
| Mosseri Marlio Charles | 10% Owner |
Dec 13 '24 |
Buy |
4.70 |
17,000 |
79,900 |
2,612,000 |
| Poradosu Enrique | Chief Science & Business Off |
Nov 19 '24 |
Buy |
4.99 |
2,000 |
9,980 |
1,506,319 |
0.95%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):